
Sign up to save your podcasts
Or


Dr. Nathaniel Huebsch is an Assistant Professor of Biomedical Engineering at Washington University in St. Louis. His lab focuses on understanding how mechanical cues originating at cell-cell and cell-extracellular matrix contacts influence signaling and fate. They are especially interested in how those cues affect heart development and disease. He talks about cardiac models and cardiomyocyte maturity.
Modeling Early Development – Peri-gastruloids model human post-implantation development into early organogenesis.
Fatty Acid Synthesis in Endoderm Differentiation – Researchers identified a fatty acid synthesis/oxidation shift during early differentiation.
Editing HSCs In Vivo – Scientists designed a strategy to reprogram bone marrow stem cells directly within the body without the need for donor cells or the use of potentially toxic conditioning regimens.
T Cell Therapy for Solid Tumors – Gavo-cel is an engineered T cell therapy tested in patients with mesothelin-expressing solid tumors.
Never miss updates about new episodes.
By The Stem Cell Podcast4.7
101101 ratings
Dr. Nathaniel Huebsch is an Assistant Professor of Biomedical Engineering at Washington University in St. Louis. His lab focuses on understanding how mechanical cues originating at cell-cell and cell-extracellular matrix contacts influence signaling and fate. They are especially interested in how those cues affect heart development and disease. He talks about cardiac models and cardiomyocyte maturity.
Modeling Early Development – Peri-gastruloids model human post-implantation development into early organogenesis.
Fatty Acid Synthesis in Endoderm Differentiation – Researchers identified a fatty acid synthesis/oxidation shift during early differentiation.
Editing HSCs In Vivo – Scientists designed a strategy to reprogram bone marrow stem cells directly within the body without the need for donor cells or the use of potentially toxic conditioning regimens.
T Cell Therapy for Solid Tumors – Gavo-cel is an engineered T cell therapy tested in patients with mesothelin-expressing solid tumors.
Never miss updates about new episodes.

90,918 Listeners

32,267 Listeners

4,169 Listeners

26,398 Listeners

765 Listeners

820 Listeners

6,444 Listeners

112,987 Listeners

56,861 Listeners

8,347 Listeners

6,578 Listeners

6,438 Listeners

16,381 Listeners

2,320 Listeners

1,645 Listeners